Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of COVID-19 Convalescent Plasma in the Patients Infected With COVID-19 (SARS-CoV-2) - Efficacy and Safety

NCT04397523 is registered in ClinicalTrials.gov with Institute for Transfusion Medicine of RNM as lead sponsor.

NCT NCT04397523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04397523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of COVID-19 Convalescent Plasma in the Patients Infected With COVID-19 (SARS-CoV-2) - Efficacy and Safety
Lead sponsor
Institute for Transfusion Medicine of RNM
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2020
Completion date
May 10, 2021
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convalescent plasma, covid-19, sars-cov 2